QuorumCivic. Hidden in plain sight Get the app
Bill intelligence

FDA to study reusing medical devices — could save hospitals millions

H.R. 10088 — To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to conduct a study to assess the potential for expanding the safe and effective use of reprocessed single-use devices, and for other purposes. · Filed by Valerie Foushee (D-NC) · Introduced Aug 13, 2026 · Referred to committee

85%
Transparency
Typical bill: 82%
5/100
Hidden-provision risk
Typical bill: 15/100
Medical Device Reprocessing Study

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill directs the FDA to study whether single-use medical devices (like catheters or surgical instruments designed to be thrown away after one use) can be safely reprocessed and reused. The study will examine existing FDA rules, the role of third-party reprocessing companies versus hospitals doing it in-house, operational and financial feasibility, liability issues, and environmental benefits. The FDA must report findings within one year, identifying which devices could be reprocessed and recommending programs to expand reprocessing.

Why we flagged it

The bill's sole operative mechanism is a directed study by the FDA on the safety and feasibility of reprocessing single-use medical devices. It is a fact-finding and reporting mandate, not a regulatory change or appropriation.

What the text implies

  • Study findings could inform future FDA rulemaking that expands reprocessing pathways, potentially reducing device manufacturer revenue if reuse becomes standard practice for certain devices.
  • Liability and accountability findings may influence hospital and third-party reprocessor behavior, potentially shifting risk allocation in ways that affect insurance and litigation patterns.

The full analysis lists 3 implications of this text.

Who stands to gain

hospitals (potential cost savings from device reuse); third-party medical device reprocessors (potential market expansion); healthcare systems (waste reduction and operational efficiency)

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record